LIGAND PHARMACEUTICALS INCORPORATED Operating Leases, Future Minimum Payments Due
LIGAND PHARMACEUTICALS INCORPORATED (LGNYZ) had Operating Leases, Future Minimum Payments Due of $2.96 million as of 2018-12-31, per its 10-K filed 2019-02-28.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDue · last filed 2019-02-28
- 2018-12-31: Operating Leases, Future Minimum Payments Due $2.96M.
- 2017-12-31: Operating Leases, Future Minimum Payments Due $3.75M.
- 2016-12-31: Operating Leases, Future Minimum Payments Due $2.76M.
- 2016-06-30: Operating Leases, Future Minimum Payments Due $3.58M.
| Period end | Operating Leases, Future Minimum Payments Due |
|---|---|
| 2018-12-31 | $2.96M 10-K · filed 2019-02-28 |
| 2017-12-31 | $3.75M 10-K · filed 2018-03-01 |
| 2016-12-31 | $2.76M 10-K · filed 2017-02-28 |
| 2016-06-30 | $3.58M 10-Q · filed 2016-11-14 |
| 2016-03-31 | $4.44M 10-Q · filed 2016-11-14 |
| 2015-12-31 | $2.98M 10-K · filed 2016-11-14 |
| 2015-09-30 | $5.22M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $6.25M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $7.65M 10-Q · filed 2015-05-11 |